Vemlidy 25mg Tablet

Vemlidy 25mg Tablet contains the active ingredient Tenofovir Disoproxil, which belongs to a class of medications known as nucleotide reverse transcriptase inhibitors (NRTIs). It is prescribed for the treatment of chronic hepatitis B virus (HBV) infection in adults and adolescents aged 12 years and older. Tenofovir Disoproxil works by blocking the activity of reverse transcriptase, an enzyme essential for the replication of HBV. This helps to reduce HBV viral load, improve liver function, and decrease the risk of liver-related complications.

Uses:

1. Chronic Hepatitis B Virus (HBV) Infection: Vemlidy 25mg Tablet is indicated for the treatment of chronic HBV infection. It helps to suppress HBV replication, reduce liver inflammation, and prevent the progression of liver disease, including cirrhosis and hepatocellular carcinoma (liver cancer).

Side Effects:

While Vemlidy 25mg Tablet is generally well-tolerated, it may cause side effects in some individuals. Common side effects associated with Tenofovir Disoproxil include:

• Nausea and Vomiting: Some patients may experience nausea and vomiting, particularly at the beginning of treatment. Taking the medication with food can help alleviate these symptoms.
• Diarrhea: Diarrhea is a common side effect of Tenofovir Disoproxil and may occur in some individuals. Maintaining adequate hydration and dietary adjustments can help manage diarrhea.
• Fatigue: Fatigue or weakness may occur during treatment with Vemlidy 25mg Tablet. Getting adequate rest and maintaining a healthy lifestyle can help manage fatigue.
• Renal Toxicity: Long-term use of Tenofovir Disoproxil may lead to renal toxicity, including kidney dysfunction and reduced kidney function. Patients should undergo regular monitoring of renal function while taking this medication.

Precautions:

• Bone Health: Tenofovir Disoproxil may cause bone loss or decrease bone mineral density, particularly with long-term use. Patients should ensure an adequate intake of calcium and vitamin D and discuss bone health with their healthcare provider.
• HIV Coinfection: Patients coinfected with HBV and HIV should use Vemlidy 25mg Tablet with caution, as this medication alone may not be sufficient to control HIV infection. Close monitoring and appropriate management of both HBV and HIV infections are necessary.
• Pregnancy and Breastfeeding: The safety of Tenofovir Disoproxil during pregnancy and breastfeeding is not well-established. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.
• Liver Dysfunction: Patients with severe liver impairment should use Vemlidy 25mg Tablet with caution, as dosage adjustments may be necessary. Close monitoring of liver function is recommended during treatment.